Journal
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
Volume 21, Issue 6, Pages 337-343Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.yic.0000215083.57801.11
Keywords
meta-analysis; obsessive-compulsive disorder; quetiapine; treatment resistant
Categories
Ask authors/readers for more resources
Small studies have shown positive effects from adding a variety of antipsychotic agents in patients with obsessive-compulsive disorder who are unresponsive to treatment with serotonin reuptake inhibitors. The evidence, however, is contradictory. This paper reports a meta-analysis of existing double-blind randomized placebo-controlled studies looking at the addition of the second-generation antipsychotic quetiapine in such cases. Three studies fulfilled the inclusion criteria. Altogether 102 individuals were subjected to analysis using Review Manager (4.2.7). The results showed evidence of efficacy for adjunctive quetiapine (< 400 mg/day) on the primary efficacy criterion, measured as changes from baseline in total Yale-Brown Obsessive Compulsive Scale scores (P=0.008), the clinical significance of which was limited by between-study heterogeneity. The mechanism underlying the effect may involve serotonin and/or dopamine neurotransmission.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available